Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Health Management Technology
|
September 12, 2003
What works: targeting populations at highest risk. IT delivers a 2:1 ROI for midwest health plan
Mary Anne Sloan
Environmental Management
|
February 9, 2008
Field validation of a conservation network on the Eastern Shore of Maryland, USA, using breeding birds as bio-indicators
Theodore C Weber, Peter J Blank, Anne Sloan
Journal of Clinical Immunology
|
December 23, 2022
XLA and Recurrent Conjunctivitis: a Unique Association?
Vyanka Redenbaugh, Anne Sloan, Jacklyn Sui, et al.
Journal of Clinical Immunology
|
January 6, 2021
Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy
Fionnuala Cox, Catherine King, Anne Sloan, et al.
The World Allergy Organization Journal
|
September 27, 2021
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective
Catherine King, Fionnuala Cox, Anne Sloan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Health Management Technology
|
September 12, 2003
What works: targeting populations at highest risk. IT delivers a 2:1 ROI for midwest health plan
Mary Anne Sloan
Environmental Management
|
February 9, 2008
Field validation of a conservation network on the Eastern Shore of Maryland, USA, using breeding birds as bio-indicators
Theodore C Weber, Peter J Blank, Anne Sloan
Journal of Clinical Immunology
|
December 23, 2022
XLA and Recurrent Conjunctivitis: a Unique Association?
Vyanka Redenbaugh, Anne Sloan, Jacklyn Sui, et al.
Journal of Clinical Immunology
|
January 6, 2021
Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy
Fionnuala Cox, Catherine King, Anne Sloan, et al.
The World Allergy Organization Journal
|
September 27, 2021
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective
Catherine King, Fionnuala Cox, Anne Sloan, et al.
Page
of 1